2171139-20-9
C25H30N2O5
438.5
Type 2 Diabetes; Weight loss
Tirzepatide
GLP-1, GIP
Availability: | |
---|---|
Product Description
Tirzepatide is a GIP receptor and GLP-1 receptor agonist. It is a 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding and prolongs the half-life. Tirzepatide selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1.
Tirzepatide enhances first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose dependent manner.
Tirzepatide Intermediate
This Tirzepatide intermediate, CAS No. 2171139-20-9, is a main chain of Tirzepatide.
Abbreviated as Fmoc-Ile-Aib-OH, it is a di-peptide (P2), and the corresponding sequence on Tirzepatide is Peptide 12 to Peptide 13.